NEW Guidance for Industry: CGMP for Phase I Investigational Drugs
Jamie Jamshidi
90 Min
Product Id: 701064
This guidance is intended to assist in applying current good manufacturing practice (CGMP) required under section 501(a) (2) (B) of the Federal Food, Drug, and Cosmetic Act (FD&C Act) in the manufacture of most investigational new drugs (IND).
Understanding Single Sampling Attributes Acceptance Sampling for Defectives. Going beyond ANSI Z1.4 and ISO 2859
John F Haury, Ph.D,CQE,CQM
90 Min
Product Id: 701055
This Sampling training will answer all your questions about acceptance sampling for defectives.
Using Electronic Health Records and Claims Databases for Rapid-Response Pharmacovigilance Studies
Alan Hochberg
60 Min
Product Id: 700972
This presentation will give an overview of these new tools and techniques for the non-statistician/epidemiologist. It is vital that a pharmaceutical manufacturer be able to quickly assess these issues on a sound statistical basis, in a way that eliminates bias due to confounding factors as much as possible.
Validating Disinfectants for Pharmaceutical and Biotech Operations
Jim Polarine
90 Min
Product Id: 701021
This Biopharmaceutical Compliance training provides guidance on industry trends, regulatory feedback, and designs for an effective validation program. Designing an effective disinfectant validation program to meet FDA and EMEA scrutiny. This webinar provides guidance on industry trends, regulatory feedback, and designs for an effective validation program. Current 483's, Warning Letters, and Field Experiences will be conveyed that allow end users to determine that best methods to validate their products against their isolates.
Packaging Validation & Shipping Qualification
Richard Gaeto
60 Min
Product Id: 701006
This presentation will discuss the differences between qualifications and validations as they apply to shipping and packaging. The objective of a shipping qualification program is to verify that product can be shipped throughout the supply chain within required temperature ranges and without damage. To accomplish this companies must conduct operational and performance qualifications for their shipping configurations. The operational qualifications consisted of temperature mapping of test loads that are challenged with “worst case” temperature profiles under controlled laboratory conditions. The performance qualifications were performed concurrent with actual product shipments.
Principles of Sterile Manufacturing
James Harris(PhD)
60 Min
Product Id: 700991
This webinar in designed to provide the basic knowledge needed to create and operate a sterile manufacturing facility.
Getting the Most Out Of Data Mining for Pharmacovigilance and Risk Management
Alan Hochberg
60 Min
Product Id: 700971
This presentation will give an overview of data mining systems, for the safety or regulatory professional who collaborates with data miners, and for the executive decision-maker who oversees the implementation of data mining.
Basic Requirements for Steam Sterilizer Validation per ISO 17665
Mark Dott
90 Min
Product Id: 700295
This Steam Sterilization training will review the general requirements for performing a steam sterilizer validation via the “overkill” half-cycle method as described in ISO 17665 (supersedes ISO 11134). For decades, steam sterilization (autoclaving) has been an integral part in the manufacturing and laboratory processes in the medical device, pharmaceutical, and HCT/P industries.
Clinical Research Organization Audit for Good Clinical Practice
Ronald Schoengold
90 Min
Product Id: 700907
This Webinar defines the role of the CRO to ensure that each party is meeting its responsibilities. CRO audits ensure that the study data and results are credible and accurate, and that the rights and well-being of study subjects have been protected.
Effective CAPA Management: How to Implement a Risk-based Approach to Improve Your Quality System
Ken Peterson
Product Id: 700994
In this course, we will introduce you to a new method of managing your CAPA system, The Gateway: A Risk-based Filter. This webinar is geared toward professionals in the QA/AC and CAPA discipline and is appropriate for individuals who are regularly called upon to resolve problems, or whose input would aid in preventing problems.
Designing an Effective Cleaning and Disinfection Program for Pharmaceutical, Biotech, and Medical Device Cleanrooms
Jim Polarine
90 Min
Product Id: 700995
This webinar will provide valuable assistance to all FDA and EMEA regulated companies that need to validate their cleaning and disinfection programs.
Investigator responsibility/Legal commitment in drug and device clinical research: the reality
Charles H Pierce
90 Min
Product Id: 700923
To follow the regulations is Good Clinical Practices (GCP) and common sense. To not know and follow these regulations is folly. This Webinar will provide invaluable assistance to investigators and staff with regulatory/ legal responsibilities. It also delves into the complex ethical considerations in pharmaceutical product (drug or device) research involving human subjects.
Introduction to Process Capability (Cp, CpK, Pp, Ppk)
Lawrence Mucha
60 Min
Product Id: 700342
This webinar will provide valuable assistance to all regulated companies that need to validate their systems In this session we will introduce basic control charting and statistical methods to determine if a process is capable of consistently producing product within specifications and how to make it capable if it is not
Organization of Clinical Datasets in eCTD Submissions
Antoinette Azevedo
90 Min
Product Id: 700992
This presentation will review the documentation requirements, the electronic navigation aids required for all the components of the electronic datasets package for a clinical study. This webinar will provide valuable assistance to all pharmaceutical and biotechnology that are conducting clinical studies with the intent of filing Investigational New Drug (IND) and New Drug Applications (NDA) or Biological License Applications (BLA) submissions.
Small GMP problems which cause the biggest enforcement headaches: how to tackle them
Steven S Kuwahara
75 Min
Product Id: 700950
The presentation will use examples taken from warning letters to illustrate some of these problems, and discuss possible solutions. As an example, we will discuss the process for accepting raw material.
Data and Safety Monitoring in Clinical Research Involving Human Subjects - When and How
Charles H Pierce
90 Min
Product Id: 700924
This webinar will provide invaluable assistance to investigators and their staff in the regulatory / legal responsibilities and also the ethical considerations in pharmaceutical product (Drug or device) research involving human subjects. All Clinical Research protocols have a prominent safety monitoring plan as part of the overall research plan / protocol. This "plan" is to ensure the safety of participating subjects and to ensure the validity and integrity of the data.
Validation Requirements Based on ICH Q9
Jamie Jamshidi
90 Min
Product Id: 700932
This program is specially designed for personnel in the Pharmaceutical and Biotechnology industries. This guidance provides principles and examples of tools for quality risk management that can be applied to different aspects of pharmaceutical quality.
Online Training for Laboratory Compliance- Pack of two courses
Dr. Ludwig Huber
120 Min
Product Id: 700996
ComplianceOnline brings you a pack of 2 courses covering two of the major compliance areas faced by Clinical Laboratories.
Pharmacovigilance aspects of licensing agreements
Dr.Sidney Kahn
60 Min
Product Id: 700928
Regulatory expectations for reporting in multi-company development and marketing programs.
Implementing a GCP Vendor Qualification Program: Ensuring your vendors are in compliance with FDA requirements
Carl Anderson
60 Min
Product Id: 700916
The presentation covers the requirements of the Code of Federal Regulations for drugs, biologics, and medical devices, as well as key FDA Guidance Documents including the International Conference on Harmonization (ICH) E6. This program is essential for management of clinical trial sponsors and vendors.







